Traf1 induction and protection from tumor necrosis factor by nuclear factor-κB p65 is independent of serine 536 phosphorylation

Carl Y. Sasaki, Colin F. Slemenda, Paritosh Ghosh, Theresa J. Barberi, Dan L. Longo

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

Abnormal nuclear factor-κB (NF-κB) signaling has been attributed to the initiation and progression of cancer. Post-translational modification of p65 facilitates optimal NF-κB signaling after activation. Here, we show that the phosphorylation of serine 536 was required for p65-mediated transcription and IκBα expression in fibroblasts. Furthermore, tumor necrosis factor (TNF) treatment slightly induced p65 phosphorylation, and both unphosphorylated and phosphorylated p65 translocated into the nucleus. The phosphorylation of serine 536 was not required for p65-mediated protection from TNF cytotoxicity and Traf1 induction in fibroblasts. Also, the corecruitment of p65 and RNA polymerase II to the Traf1 enhancer region did not require p65 phosphorylation. However, the corecruitment of p65 and RNA polymerase II to the Csf2 promoter required the phosphorylation of serine 536. These findings suggested that the requirement of serine phosphorylation at residue 536 and the distance between the NF-κB response element and the start of transcription may influence which genes will be transcribed.

Original languageEnglish (US)
Pages (from-to)11218-11225
Number of pages8
JournalCancer Research
Volume67
Issue number23
DOIs
StatePublished - Dec 1 2007
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Traf1 induction and protection from tumor necrosis factor by nuclear factor-κB p65 is independent of serine 536 phosphorylation'. Together they form a unique fingerprint.

Cite this